Enzychem Lifesciences Corporation (KOSDAQ:183490)

Enzychem Lifesciences Revenue

Enzychem Lifesciences had revenue of 14.89B KRW in the quarter ending March 31, 2026, a decrease of -28.34%. This brings the company's revenue in the last twelve months to 61.86B, down -18.52% year-over-year. In the year 2025, Enzychem Lifesciences had annual revenue of 67.75B, down -12.44%.

• Revenue (ttm): 61.86B
• Revenue Growth: -18.52%
• P/S Ratio: 1.24
• Revenue / Employee: 475.85M
• Employees: 130
• Market Cap: 76.86B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	67.75B	-9.63B	-12.44%
Dec 31, 2024	77.38B	1.34B	1.76%
Dec 31, 2023	76.04B	49.40B	185.46%
Dec 31, 2022	26.64B	3.66B	15.94%
Dec 31, 2021	22.98B	-2.84B	-11.01%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 10, 2026

Data Sources Report a data error